T. Rowe Price Health Sciences earns a Morningstar Analyst Rating of Silver because of its capable, well-resourced team and strong investment process parameters.
- NAV / 1-Day Return 87.40 / 0.41 %
- Total Assets 14.8 Bil
-
Adj. Expense Ratio
0.800%
- Expense Ratio 0.800%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield —
- Turnover 29%
Morningstar’s Analysis PRHSX
Will PRHSX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
Process Pillar
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings 152
- Bond Holdings 0
- Other Holdings 4
- % Assets in Top 10 Holdings 47.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
Aggregate Miscellaneous Equity
9.46
1,482,953,256
—